When.com Web Search

  1. Ads

    related to: is there a cure for sickle cell anemia coming soon

Search results

  1. Results From The WOW.Com Content Network
  2. FDA approves cure for sickle cell disease, the first ... - AOL

    www.aol.com/news/fda-approves-cure-sickle-cell...

    December 8, 2023 at 1:19 PM. The Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease, a devastating illness that affects more than 100,000 Americans, the ...

  3. FDA advisers review sickle cell treatment that could cure the ...

    www.aol.com/fda-advisers-review-sickle-cell...

    The Food and Drug Administration says there’s an unmet need for help for patients suffering from severe sickle cell anemia. A new drug that uses gene editing could solve that.

  4. New sickle cell treatment sparks feelings of hope and some ...

    www.aol.com/news/sickle-cell-treatment-sparks...

    Although about 1,500 people are treated for sickle cell in Mount Sinai’s program, Glassberg estimated that less than 10% will opt to get the new treatment if it’s approved — in part because ...

  5. Exagamglogene autotemcel - Wikipedia

    en.wikipedia.org/wiki/Exagamglogene_autotemcel

    The treatment was approved in the United Kingdom for the treatment of sickle cell disease and transfusion-dependent beta thalassemia in November 2023. [9] [10] [11] It was approved in the United States for the treatment of sickle cell disease in December 2023 and for the treatment of transfusion-dependent beta thalassemia in January 2024. [8 ...

  6. Voxelotor - Wikipedia

    en.wikipedia.org/wiki/Voxelotor

    Voxelotor. Voxelotor, sold under the brand name Oxbryta, is a medication used for the treatment of sickle cell disease. [1][3][4][5][6] Voxelotor is the first hemoglobin oxygen-affinity modulator. [7] Voxelotor has been shown to have disease-modifying potential by increasing hemoglobin levels and decreasing hemolysis indicators in sickle cell ...

  7. Crizanlizumab - Wikipedia

    en.wikipedia.org/wiki/Crizanlizumab

    146 232.04 g·mol −1. Crizanlizumab, sold under the brand name Adakveo among others, is a monoclonal antibody medication that binds to P-selectin. [3] It is a medication used to reduce the frequency of vaso-occlusive crisis in people aged 16 years and older who have sickle cell anemia. [3][4][6] It is given by injection into a vein. [3][4 ...

  1. Ad

    related to: is there a cure for sickle cell anemia coming soon